Article
Medicine, General & Internal
Chirag D. Jhaveri, Adam R. Glassman, Frederick L. Ferris, Danni Liu, Maureen G. Maguire, John B. Allen, Carl W. Baker, David Browning, Matthew A. Cunningham, Scott M. Friedman, Lee M. Jampol, Dennis M. Marcus, Daniel F. Martin, Carin M. Preston, Cynthia R. Stockdale, Jennifer K. Sun
Summary: The relative efficacy of administering aflibercept monotherapy compared with bevacizumab followed by aflibercept if there is insufficient improvement in eyes with diabetic macular edema is uncertain.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Ophthalmology
Imoro Zeba Braimah, Winfried M. Amoaku
Summary: The study found that intravitreal ziv-aflibercept (IVZ) is associated with significant improvement in best-corrected visual acuity (BCVA) and reduction in central macular thickness (CMT) in patients with diabetic macular edema (DME).
Article
Ophthalmology
Maya H. Maloney, Stephanie R. Payne, Jeph Herrin, Lindsey R. Sangaralingham, Nilay D. Shah, Andrew J. Barkmeier
Summary: This study aimed to compare the systemic safety of intravitreal bevacizumab, ranibizumab, and aflibercept in real-world clinical practice. The results showed no significant differences in the risk of acute myocardial infarction, acute cerebrovascular disease, major bleeding, or all-cause hospitalization after treatment initiation with any of the three anti-VEGF agents.
Article
Multidisciplinary Sciences
Martin Hein, Aleksandar Vukmirovic, Ian J. Constable, Vignesh Raja, Arman Athwal, K. Bailey Freund, Chandrakumar Balaratnasingam
Summary: This study aims to identify biomarkers that predict improvement in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) in eyes with diabetic macular edema (DME) treated with intravitreal aflibercept. The study found that glycosylated hemoglobin, renal function, dyslipidemia, hypertension, cardiovascular disease and smoking were associated with treatment response. Baseline imaging, systemic and demographic variables showed associations with BCVA and CRT change post aflibercept. Predictors of BCVA improvement included macular vessel density and LDL level, while predictors of CRT reduction included peripheral non-perfusion and LDL level. These results may help better-select patients who will benefit from intravitreal aflibercept for DME treatment.
SCIENTIFIC REPORTS
(2023)
Article
Multidisciplinary Sciences
Takao Hirano, Yuichi Toriyama, Yoshihiro Takamura, Masahiko Sugimoto, Taiji Nagaoka, Yoshimi Sugiura, Fumiki Okamoto, Michiyuki Saito, Kousuke Noda, Shigeo Yoshida, Akihiro Ishibazawa, Osamu Sawada, Toshinori Murata
Summary: This study demonstrated that a 2-year treat-and-extend aflibercept regimen, combined with adjunct focal/grid laser, could effectively improve BCVA and CST in patients with diabetic macula edema.
SCIENTIFIC REPORTS
(2021)
Article
Multidisciplinary Sciences
Tomoya Murakami, Fumiki Okamoto, Yoshimi Sugiura, Shohei Morikawa, Yoshifumi Okamoto, Takahiro Hiraoka, Tetsuro Oshika
Summary: The aim of this study was to investigate the changes in metamorphopsia in patients with diabetic macular edema (DME) following intravitreal aflibercept injection (IVA) with the treat and extend (TAE) regimen for one year. The study findings showed that the metamorphopsia score in patients with DME improved following IVA with the TAE regimen, and the presence of an epiretinal membrane (ERM) was associated with the metamorphopsia score.
SCIENTIFIC REPORTS
(2022)
Article
Ophthalmology
David W. Hutton, Adam R. Glassman, Joshua D. Stein, Neil M. Bressler, Jennifer K. Sun
Summary: The study found that similar visual outcomes were obtained on average when managing CI-DME and good baseline VA patients initially with laser or observation strategies compared to the immediate use of aflibercept. While individual circumstances may warrant any of these three strategies, on a societal level, cost savings might be achieved with these first two approaches.
AMERICAN JOURNAL OF OPHTHALMOLOGY
(2021)
Article
Endocrinology & Metabolism
Karen Mulligan, Jaehong Kim, Bryan Tysinger, Jill Blim, Geoffrey Emerson, Philip J. Ferrone, Judy E. Kim, Seth Seabury, Paul Hahn
Summary: This study simulates economic outcomes for individuals with diabetic macular edema (DME) and finds that treatment significantly improves patients' vision, life expectancy, and quality of life, as well as positively affects employment and disability outcomes.
Article
Ophthalmology
David W. W. Hutton, Adam R. R. Glassman, Danni Liu, Jennifer K. K. Sun
Summary: There was no significant difference in visual outcomes between aflibercept monotherapy and bevacizumab-first strategies for treating diabetic macular edema over 2 years. Understanding the cost and cost-effectiveness of these approaches is important.
JAMA OPHTHALMOLOGY
(2023)
Article
Multidisciplinary Sciences
Tomoaki Tatsumi, Yoko Takatsuna, Toshiyuki Oshitari, Tomomi Kaiho, Yohei Kawasaki, Yuki Shiko, Takeshi Sugawara, Takayuki Baba, Shuichi Yamamoto
Summary: This study compared the efficacy and safety of intravitreal aflibercept combined with subthreshold laser therapy to intravitreal aflibercept monotherapy for treating diabetic macular edema. The results showed that the combination therapy did not reduce the number of injections needed and there was no significant difference in treatment outcomes between the two groups.
SCIENTIFIC REPORTS
(2022)
Article
Ophthalmology
Carlos D. Nunez-Amaro, Mariana Lopez, Elva Adan-Castro, Ma. Ludivina Robles-Osorio, Renata Garcia-Franco, Marlon Garcia-Roa, Yolanda Villalpando-Gomez, Paulina Ramirez-Neria, Nayeli Pineiro, Juan Fernando Rubio-Mijangos, Jorge Sanchez, Gabriela Ramirez-Hernandez, Lourdes Siqueiros-Marquez, Nundehui Diaz-Lezama, Ellery Lopez-Star, Thomas Bertsch, Gonzalo Marinez de la Escalera, Jakob Triebel, Carmen Clapp
Summary: Oral levosulpiride for 8 weeks improved visual and structural outcomes in patients with centre-involving diabetic macular oedema (DME) by mechanisms that may include intraocular upregulation of vasoinhibin and downregulation of VEGF and PlGF. Larger clinical trials evaluating long-term efficacy and safety are warranted.
Article
Ophthalmology
E. E. Cornish, S. Wickremasinghe, H. Mehta, L. Lim, S. S. Sandhu, V. Nguyen, M. C. Gillies, S. Fraser-Bell
Summary: The study aimed to determine whether targeted retinal laser photocoagulation (TPRP) to peripheral retinal ischaemia reduces the number of aflibercept injections needed for treating diabetic macular oedema (DMO) over a 24-month period. The results showed that combination therapy of laser and aflibercept did not reduce the overall burden of aflibercept injections.
Review
Immunology
Moein Ebrahimi, Maryam Balibegloo, Nima Rezaei
Summary: This article presents a review of monoclonal antibodies (mAbs), bevacizumab and ranibizumab, in diabetic retinopathy (DR), including their advantages, challenges, and limitations. It also proposes new ideas to overcome these limitations, such as identifying additional therapeutic targets, exploring alternative treatment regimens, and improving drug delivery methods.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Ji Soo Kim, Seungheon Lee, Jin Young Kim, Eoi Jong Seo, Ju Byung Chae, Dong Yoon Kim
Summary: Approximately 30% of DME patients were lost to follow-up for more than 1 year during anti-VEGF treatment, leading to permanent visual loss in some cases. Patients at high risk of being lost to follow-up, such as males, those with early diabetes mellitus, and poor responders after initial injections, should be managed more aggressively to improve visual outcomes.
SCIENTIFIC REPORTS
(2021)
Article
Ophthalmology
Sobha Sivaprasad, Faruque Ghanchi, Simon P. P. Kelly, Ajay Kotagiri, James Talks, Peter Scanlon, Hellen McGoey, Andrew Nolan, Moneeb Saddiq, Jackie Napier, Peter Morgan-Warren
Summary: This study examines the treatment pathway and service provision for patients with diabetic macular oedema receiving anti-vascular endothelial growth factor treatment, and finds that patients were promptly treated upon diagnosis, with most visits being combined treatment and assessment or monitoring only. The study also reveals that non-physicians administered most of the intravitreal aflibercept injections with a similar safety profile compared to injections administered by physicians.
Editorial Material
Ophthalmology
Andrea Montesel, Chiara M. Eandi, Leonidas Zografos
Summary: This article describes a rare unilateral association between an iris stromal tumor and a macular focal choroidal excavation. A 40-year-old patient was found to have a small iris tumor and a macular lesion in one eye during a routine eye examination. The patient was asymptomatic and had normal visual function. After evaluation, the diagnosis of a nonmelanocytic undefined stromal tumor of the iris associated with macular focal choroidal excavation was made. The size and shape of the lesions remained stable during a 7-year follow-up, and no other symptoms developed. Further reports are necessary to understand the exact pathogenesis of this association.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
(2023)
Article
Ophthalmology
Andrea Montesel, Anthony Gigon, Clarice Giacuzzo, Irmela Mantel, Chiara M. Eandi
Summary: This study investigated the impact of deferring intravitreal injection treatment during the COVID-19 lockdown on patients with neovascular age-related macular degeneration. Patients who continued treatment according to schedule showed stable visual acuity and central subfield thickness, while those who deferred treatment experienced irreversible deterioration in visual function. Treatment continuation is recommended for patients with neovascular age-related macular degeneration during a lockdown.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
(2022)
Article
Cell Biology
Giovanni Giurdanella, Anna Longo, Alfio Distefano, Melania Olivieri, Martina Cristaldi, Alessia Cosentino, Aleksandra Agafonova, Nunzia Caporarello, Gabriella Lupo, Carmelina Daniela Anfuso
Summary: This study evaluated the modulatory effect of the selective beta 1-adrenoreceptor antagonist metoprolol on the inflammatory response to hyperglycemic conditions. The results showed that metoprolol could reduce cell death and modulate the angiogenic potential, while decreasing the expression levels of inflammatory cytokines and angiogenesis-related genes. Furthermore, metoprolol inhibited the activation of the inflammatory signaling pathway and the accumulation of reactive oxygen species (ROS), while activating the anti-oxidative cellular response pathway.
Article
Medicine, Research & Experimental
Tho X. Pham, Jisu Lee, Jiazhen Guan, Nunzia Caporarello, Jeffrey A. Meridew, Dakota L. Jones, Qi Tan, Steven K. Huang, Daniel J. Tschumperlin, Giovanni Ligresti
Summary: This study identified the gene programs driving persistent lung fibrosis in aging by analyzing the RNA of lung fibroblasts from young and aged mice. The findings suggested that PIM1 and NFATc1 may play a role in the sustained profibrotic gene expression in aged fibroblasts. Targeting this pathway could potentially be a therapeutic strategy for idiopathic pulmonary fibrosis (IPF).
Article
Multidisciplinary Sciences
Nunzia Caporarello, Jisu Lee, Tho X. Pham, Dakota L. Jones, Jiazhen Guan, Patrick A. Link, Jeffrey A. Meridew, Grace Marden, Takashi Yamashita, Collin A. Osborne, Aditya Bhagwate, Steven K. Huang, Roberto F. Nicosia, Daniel J. Tschumperlin, Maria Trojanowska, Giovanni Ligresti
Summary: Vascular dysfunction plays a significant role in aging and chronic diseases, but its involvement in lung repair and fibrosis remains unclear. In this study, the authors identified the endothelial transcription factor ERG as a mediator of vascular repair, whose function declines in aged lungs, resulting in sustained fibrosis. These findings highlight the importance of understanding the mechanisms underlying vascular dysfunction in lung fibrosis and provide potential targets for therapeutic interventions.
NATURE COMMUNICATIONS
(2022)
Article
Neurosciences
Alessandro Rodolico, Carmen Concerto, Alessia Ciancio, Spyridon Siafis, Laura Fusar-Poli, Carla Romano, Elisa Scavo, Antonino Petralia, Salvatore Salomone, Maria Signorelli, Stefan Leucht, Eugenio Aguglia
Summary: The study translated the GASS scale into Italian to assess the validity and feasibility of evaluating side effects reported by patients receiving antipsychotic drugs. The GASS showed modest structural validity and good internal consistency, but was not optimal in identifying side effects.
Article
Pharmacology & Pharmacy
Alessia Romeo, Angela Bonaccorso, Claudia Carbone, Gabriella Lupo, Carmelina Daniela Anfuso, Giovanni Giurdanella, Cinzia Caggia, Cinzia Randazzo, Nunziatina Russo, Giovanni Luca Romano, Claudio Bucolo, Milena Rizzo, Giovanni Tosi, Jason Thomas Duskey, Barbara Ruozi, Rosario Pignatello, Teresa Musumeci
Summary: This study designed and optimized melatonin-loaded lipid-polymer hybrid nanoparticles (mel-LPHNs) for the topical management of retinal diseases. The optimized nanomedicine showed suitable characteristics for ophthalmic administration, including good mucoadhesive properties, controlled release profile, and increased neuroprotective and antioxidant activities compared to melatonin aqueous solution. The development of mel-LPHNs provides a novel and safe hybrid platform for the localized treatment of retinal diseases.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
(2022)
Article
Plant Sciences
Velia D'Agata, Agata Grazia D'Amico, Grazia Maugeri, Claudio Bucolo, Settimio Rossi, Salvatore Giunta
Summary: This study found that carnosol can protect retinal vascular endothelium from the damage caused by high glucose by activating the Nrf2/HO-1 signaling pathway. This suggests that carnosol may be a valuable drug for the treatment of diabetic retinopathy.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
(2023)
Article
Physiology
Kalpana R. Betageri, Patrick A. Link, Andrew J. Haak, Giovanni Ligresti, Daniel J. Tschumperlin, Nunzia Caporarello
Summary: A protein called CCN3 plays a critical role in lung endothelial function and may be a promising therapeutic target to limit the progression of idiopathic pulmonary fibrosis (IPF).
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Nunzia Caporarello, Giovanni Ligresti
Summary: Lungs have the ability to regenerate in response to injury, but sustained injuries, aging, and genomic instability make them susceptible to disrepair and fibrosis. Pulmonary fibrosis is a major cause of morbidity, and the dysfunction of the pulmonary vasculature contributes to its progression. This review summarizes current findings related to lung vascular repair and provides insights into the development of persistent lung fibrosis.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Martina Di Bartolomeo, Tibor Stark, Serena Di Martino, Fabio Arturo Iannotti, Jana Ruda-Kucerova, Giovanni Luca Romano, Martin Kuchar, Samuele Laudani, Petr Palivec, Fabiana Piscitelli, Carsten T. Wotjak, Claudio Bucolo, Filippo Drago, Vincenzo Di Marzo, Claudio D'Addario, Vincenzo Micale
Summary: Adolescent exposure to cannabinoids, such as THC, may increase the risk of psychosis in individuals exposed to perinatal insult. In this study, the researchers examined the effects of peripubertal THC exposure on rats that were also exposed to prenatal methylazoxymethanol acetate (MAM) or perinatal THC (pTHC). They found that the rats exposed to MAM or pTHC exhibited adult phenotypes relevant to schizophrenia, including social withdrawal and cognitive impairment. The researchers also observed changes in gene expression and DNA methylation, suggesting potential molecular mechanisms underlying these effects.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Chemistry, Medicinal
Salvatore Giunta, Agata Grazia D'Amico, Grazia Maugeri, Claudio Bucolo, Giovanni Luca Romano, Settimio Rossi, Chiara M. Eandi, Elisabetta Pricoco, Velia D'Agata
Summary: In the area of drug discovery, repurposing strategies are used to discover new uses of approved drugs. In this study, the effects of DMF on early injury associated with diabetic retinopathy were investigated. The results showed that DMF can counteract the inflammatory process and the oxidative response in diabetic retinopathy.
Review
Medicine, General & Internal
Naomi Osakabe, Sergio Modafferi, Maria Laura Ontario, Francesco Rampulla, Vincenzo Zimbone, Maria Rita Migliore, Tilman Fritsch, Ali S. Abdelhameed, Luigi Maiolino, Gabriella Lupo, Carmelina Daniela Anfuso, Elisabetta Genovese, Daniele Monzani, Uwe Wenzel, Edward J. Calabrese, R. Martin Vabulas, Vittorio Calabrese
Summary: There is significant interest in finding effective strategies to prevent and slow the onset of hearing loss. Research suggests that protective dietary supplements, such as polyphenols, can help protect cochlear neural stem cells from aging and noise-related damage. These studies also show that polyphenols exhibit a biphasic dose-response pattern, with low doses having beneficial effects and high doses potentially becoming ineffective or harmful. Furthermore, polyphenols targeting the Nrf2 pathway show promise in reducing oxidative stress and inflammation, thus preventing degeneration of auditory hair cells and XIII cranial/auditory nerve cells.
MEDICINA-LITHUANIA
(2023)
Article
Medicine, General & Internal
Anthony Gigon, Maria Vadala, Vincenza M. E. Bonfiglio, Michele Reibaldi, Chiara M. Eandi
Summary: This study evaluated the efficacy of brolucizumab IVI for type 3 neovascularization in nAMD using OCTA. The results showed that brolucizumab IVI has good short-term efficacy for the treatment of type 3 neovascularization.
MEDICINA-LITHUANIA
(2022)
Article
Pharmacology & Pharmacy
Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Ali, Alessandra Ottani, Eleonora Vandini, Patrizia Guidi, Margherita Bernardeschi, Veronica La Rocca, Giulio Francia, Gabriella Fontanini, Mauro Pistello, Giada Frenzilli, Daniela Giuliani, Marco Scarselli, Guido Bocci
Summary: This study investigates the role of MC4R in melanoma and the use of the selective antagonist ML in combination with vemurafenib. The results show that ML can inhibit melanoma cell proliferation and induce apoptosis through the inhibition of ERK1/2 phosphorylation and reduction of BCL-XL expression. The combination of vemurafenib and ML exhibits a synergistic effect in vitro and inhibits tumor growth in vivo without causing adverse effects.
BIOCHEMICAL PHARMACOLOGY
(2024)
Article
Pharmacology & Pharmacy
Conor J. Bloxham, Katina D. Hulme, Fabrizio Fierro, Christian Fercher, Cassandra L. Pegg, Shannon L. O'Brien, Simon R. Foster, Kirsty R. Short, Sebastian G. B. Furness, Melissa E. Reichelt, Masha Y. Niv, Walter G. Thomas
Summary: Bitter taste receptors (T2Rs) are a type of G protein-coupled receptors that allow humans to detect aversive and toxic substances. This study characterized the functional properties of previously identified T2Rs in human cardiac tissues and their naturally occurring polymorphisms. The results showed differences in signaling among different T2R variants, and revealed a potential association between the T2R50 Tyr203 variant and cardiovascular disease.
BIOCHEMICAL PHARMACOLOGY
(2024)
Article
Pharmacology & Pharmacy
Lu Chen, Huanying Shi, Wenxin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang, Qunyi Li
Summary: This study demonstrates that Carfilzomib exhibits potent anti-tumor activity against esophageal squamous cell carcinoma (ESCC) by triggering mitochondrial apoptosis and reprogramming cellular metabolism. It has been identified that activating transcription factor 3 (ATF3) plays a crucial role as a cellular target in ESCC cells treated with Carfilzomib. Overexpression of ATF3 effectively counteracts the effects of Carfilzomib on ESCC cell proliferation, apoptosis, and metabolic reprogramming. Furthermore, ATF3 mediates the anti-tumor activity of Carfilzomib, suggesting its potential as a therapeutic agent for ESCC.
BIOCHEMICAL PHARMACOLOGY
(2024)
Review
Pharmacology & Pharmacy
Xing Zhang, Xiang Li, Ran Xia, Hong-Sheng Zhang
Summary: This review summarizes recent progress on the mechanisms of ferroptosis resistance in cancer and highlights the role of redox status and metabolism. Combination therapy for ferroptosis has great potential in treating resistant malignant tumors.
BIOCHEMICAL PHARMACOLOGY
(2024)